Enzymatic Adaptation of Bifidobacterium bifidum to Host Glycans, Viewed from Glycoside Hydrolyases and Carbohydrate-Binding Modules
Open accessAbstract
Certain species of the genus Bifidobacterium represent human symbionts. Many studies have shown that the establishment of symbiosis with such bifidobacterial species confers various beneficial effects on human health. Among the more than ten (sub)species of human gut-associated Bifidobacterium that have significantly varied genetic characteristics at the species level, Bifidobacterium bifidum is unique in that it is found in the intestines of a wide age group, ranging from infants to adults. This species is likely to have adapted to efficiently degrade host-derived carbohydrate chains, such as human milk oligosaccharides (HMOs) and mucin O-glycans, which enabled the longitudinal colonization of intestines. The ability of this species to assimilate various host glycans can be attributed to the possession of an adequate set of extracellular glycoside hydrolases (GHs). Importantly, the polypeptides of those glycosidases frequently contain carbohydrate-binding modules (CBMs) with deduced affinities to the target glycans, which is also a distinct characteristic of this species among members of human gut-associated bifidobacteria. This review firstly describes the prevalence and distribution of B. bifidum in the human gut and then explains the enzymatic machinery that B. bifidum has developed for host glycan degradation by referring to the functions of GHs and CBMs. Finally, we show the data of co-culture experiments using host-derived glycans as carbon sources, which underpin the interesting altruistic behavior of this species as a cross-feeder.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous studies of B. bifidum and other HBS have focused more on descriptive aspects.
“adds to the results of previous studies, which have focused more on descriptive aspects in B. bifidum [29,104] and other HBS [105-107]”
From Genome-scale insights into the metabolic landscape and evolutionary development of Bifidobacterium bifidum (2026) · cites this paper as [104]
Section 2, “Prevalence and Dominance of B. bifidum in the Gut,” describes its distribution and summarizes prevalence studies, supporting the characterization of descriptive work on B. bifidum. But Section 7, “Co-Culture Experiments,” also presents experimental results, so this paper is not solely descriptive. The citations to other HBS are separate from this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 105 · Cited by 80
Research works printed but not linked: 1
- [8]Laursen M.F. Sakanaka M. von Burg N. Andersen D. Mörbe U. Rivollier A. Pekmez C.T. Moll J.M. Michaelsen K.F. Mølgaard C. Breastmilk-promoted bifidobacteria produce aromatic lactic acids in the infant gut bioRxiv 2020 2020.01.22.914994
- Authors
- Katoh, T., Ojima, M. N., Sakanaka, M., Ashida, H., Gotoh, A., & Katayama, T.
- Affiliations
- Kyoto University (JP)
- Ishikawa Prefectural University (JP)
- Kindai University (JP)
- Corresponding author
- Katayama, Takane
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2020-03-28
- Volume
- 8
- Issue
- 4
- Pages
- 481
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC7232152
- OpenAlex
- W3013999313
- Cited by
- 80
- References
- 105
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 15 · 2023: 13 · 2022: 9 · 2021: 14 · 2020: 5
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (19K05789, 19K15732, 18K14379, 19K22277, 19J14598, 17J08530, 201860637)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Keywords
- Bifidobacterium bifidum, glycoside hydrolases, carbohydrate-binding module, human milk oligosaccharides, mucin O-glycans, intestinal colonization, cross-feeding, symbiosis, human gut microbiome, extracellular enzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review